James T. Boyle Jr., EVP, CEO of Lab Corporate Diagnostics at LABORATORY CORP OF AMERICA HOLDINGS (LH), sold 1,394 shares at $126.56 ($176K) on 2015-04-23, disclosed to the SEC on 2015-04-27.
Scheduled sale ($176k) by EVP, CEO of Lab Corporate Diagnostics under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $126.56 | 200 | $25K | 14.3% |
| 2 | $126.56 | 1,194 | $151K | 85.7% |
| Total | $126.56 avg | 1,394 | $176K | 100% |
| Filing → |
| LH | SELL | 2016-02-18 | $835K | — | Filing → |
| LH | SELL | 2016-02-16 | $276K | — | Filing → |
| LH | SELL | 2015-03-04 | $153K | — | Filing → |